Association of an activated clotting time ≤250 seconds with adverse event rates after percutaneous coronary intervention using tirofiban and heparin (a TACTICS-TIMI 18 substudy)

✍ Scribed by Duane S. Pinto; David P. Lorenz; Sabina A. Murphy; Susan J. Marble; Peter M. DiBattiste; Laura A. Demopoulos; Christopher P. Cannon; C.Michael Gibson

• Book ID: 113976533
• Publisher: Elsevier Science
• Year: 2003
• Tongue: English
• Weight: 78 KB
• Volume: 91
• Category: Article
• ISSN: 0002-9149
• DOI: 10.1016/s0002-9149(03)00117-6